NCT03697109: An ongoing trial by Corcept Therapeutics
This trial is ongoing. It must report results 1 week, 1 day from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03697109 |
|---|---|
| Title | Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 15, 2018 |
| Completion date | April 8, 2024 |
| Required reporting date | April 8, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |